Promising Results for Napabucasin Plus Nab-Paclitaxel With Gemcitabine in Pancreatic Cancer
June 14th 2017Tanios Bekaii-Saab, MD, professor of Medicine, Mayo Clinic, discusses results of the CanStem111P trial, a phase III study of napabucasin plus nab-paclitaxel with gemcitabine in adult patients with metastatic pancreatic adenocarcinoma.
Watch
Efficacy and Safety Results for Pembrolizumab in Previously Treated Gastric Cancer
June 13th 2017Charles S. Fuchs, MD, MPH, professor of Medicine, director, Yale Cancer Center, and physician-in-chief, Smilow Cancer Hospital, discusses efficacy and safety results for pembrolizumab (Keytruda) monotherapy in patients with previously treated advanced gastric cancer.
Watch
How Care for Merkel Cell Carcinoma Has Been Revolutionized in Recent Years
June 13th 2017Ragini R. Kudchadkar, MD, assistant professor, department of Hematology and Medical Oncology, Emory University School of Medicine, discusses how care for Merkel cell carcinoma has been revolutionized in recent years.
Watch
Advancements in the Multiple Myeloma Treatment Paradigm
June 12th 2017Sagar Lonial, MD, professor and chair, Department of Hematology & Medical Oncology, Emory University School of Medicine, chief medical officer, Winship Cancer Institute of Emory University, discusses recent advancements in the treatment paradigm for multiple myeloma.
Watch
Comparing Blue Light and White Light Cytoscopy in the Detection of Bladder Cancer
June 9th 2017Siamak Daneshmand, MD, associate professor of Urology, Director of Clinical Research, Keck School of Medicine of USC, discusses blue light cystoscopy compared with white light cystoscopy for patients with bladder cancer.
Watch